Skip to main content
OpenTrials
Completed

NCT Number: NCT02386202

ARC in Hemorrhagic Stroke

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of North Carolina Hospitals

Chapel Hill, North Carolina, 27599, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults ≥ 18 years
  • Patients with hemorrhagic stroke
  • Anticipated length of stay in the neuroscience intensive care unit > 48 hours
  • Informed consent provided by the patient or by the patient's designated medical proxy

Exclusion criteria

  • Pregnancy
  • Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5)
  • Patients receiving renal replacement therapy
  • Patients with an admission serum creatinine > 1.4 mg/dL
  • Patients with non-aneurysmal subarachnoid hemorrhage
  • Patients with history of nephrectomy or body mass index < 18 kg/m2

Treatment and study plan

No intervention

Other

No interventions

Primary outcomes

  1. To describe the onset, magnitude, and change over time of ARC in patients with hemorrhagic stroke

    Time frame: Over neurosciences intensive care unit stay

    Daily 8-hour urine collections will be performed to directly measure creatinine clearance up to ICU discharge

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Registry information

Official study title

Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit

Important dates

Study start
2015
Primary completion
2015
Study completion
2015
First posted
Mar 11, 2015
Registry last updated
Dec 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.